<DOC>
	<DOC>NCT00437242</DOC>
	<brief_summary>This study is being completed to demonstrate the lack of effect of repeat dosing with Odiparcil on the QTc interval.</brief_summary>
	<brief_title>Odiparcil QT Definitive Study</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Inclusion: Healthy volunteers Exclusion: Cardiac abnormalities Hepatic or renal insufficiency Anticoagulant medications Bleeding history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>interval,</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>QT,</keyword>
	<keyword>odiparcil,</keyword>
</DOC>